Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

Inhalation Sciences Sweden

0.31 SEK

+4.67 %

Less than 1K followers

ISAB

Spotlight Stock Market

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Investor consensus
Compare
+4.67 %
-29.91 %
-39.03 %
-37.20 %
-80.37 %
-80.20 %
-93.59 %
-96.97 %
-96.20 %

Inhalation Sciences Sweden, ISAB, is a research company. The company focuses primarily on the production and development of laboratory instruments. The instruments are used to measure particles in inhaled air and how the composition of the air affects the lungs. The company sells products under various brands, mainly on the European market. Inhalation Sciences Sweden was founded in 2004 and is headquartered in Huddinge.

Read more
Market cap
12.3M SEK
Turnover
318.1K SEK
Revenue
11.05M
EBIT %
-45.97 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
27/2
2026

Annual report '25

11/5
2026

Interim report Q1'26

All
Press releases
ShowingAll content types
Regulatory press release18 hours ago

Inhalation Sciences receives purchase order worth 160 KEUR from international distributor for the US market

Inhalation Sciences Sweden
Regulatory press release11/21/2025, 7:30 AM

Inhalation Sciences AB (publ) publicerar delårsrapport för det tredje kvartalet 2025

Inhalation Sciences Sweden
Regulatory press release11/4/2025, 7:30 AM

Inhalation Sciences hires advisors to evaluate potential acquirers of the company or the company's operations

Inhalation Sciences Sweden

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release11/4/2025, 7:30 AM

Inhalation Sciences anlitar rådgivare för att utvärdera möjliga förvärvare av bolaget eller bolagets verksamhet

Inhalation Sciences Sweden
Regulatory press release10/24/2025, 6:30 AM

Inhalation Sciences receives IRS order from leading European university hospital

Inhalation Sciences Sweden
Press release10/7/2025, 7:00 AM

Inhalation Sciences to Present abstracts from the FDA-Funded Evaluation Study on DissolvIt® and the APRINHA Project at the 2025 DDL Conference

Inhalation Sciences Sweden
Press release10/2/2025, 6:30 AM

Inhalation Sciences receives service orders from recurring global pharma customers

Inhalation Sciences Sweden
Press release9/19/2025, 6:30 AM

Inhalation Sciences: University of Liège highlights the value of PreciseInhale® in advancing Inhalation Research

Inhalation Sciences Sweden
Press release9/17/2025, 11:45 AM

Inhalation Sciences launches marketing campaign to increase awareness

Inhalation Sciences Sweden
Press release9/1/2025, 1:45 PM

Inhalation Sciences publicerar videointervju med vd och försäljnings- och marknadschef - kommenterar Q2 rapport och aktiviteter framåt

Inhalation Sciences Sweden
Regulatory press release8/29/2025, 6:39 AM

Komplettering: Inhalation Sciences AB (publ) publicerar delårsrapport för det andra kvartalet 2025

Inhalation Sciences Sweden
Regulatory press release8/29/2025, 6:00 AM

Inhalation Sciences AB (publ) publicerar delårsrapport för det andra kvartalet 2025

Inhalation Sciences Sweden
Press release7/1/2025, 8:00 AM

Inhalation Sciences receives service order from recurring global pharmaceutical customer

Inhalation Sciences Sweden
Regulatory press release6/24/2025, 2:28 PM

Kommuniké från årsstämma i Inhalation Sciences

Inhalation Sciences Sweden
Regulatory press release6/23/2025, 6:00 AM

Inhalation Sciences meddelar första dag för handel med teckningsoptioner av serie TO2 och TO3

Inhalation Sciences Sweden
Regulatory press release6/18/2025, 6:00 AM

Inhalation Sciences meddelar sista dag för handel med BTU

Inhalation Sciences Sweden
Regulatory press release6/4/2025, 3:40 PM

Inhalation Sciences offentliggör utfall i bolagets företrädesemission

Inhalation Sciences Sweden
Press release6/2/2025, 6:00 AM

Inhalation Sciences har genomfört framgångsrikt webbinarium gällande FDA-finansierad DissolvIt[®]-studie

Inhalation Sciences Sweden
Press release5/30/2025, 6:00 AM

Inhalation Sciences: Ny försäljningschef tecknar i den pågående företrädesemissionen

Inhalation Sciences Sweden
Regulatory press release5/28/2025, 6:00 AM

Inhalation Sciences meddelar sista dag för handel med uniträtter

Inhalation Sciences Sweden
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.